Skip to content

Interleukin-22 receptor subunit alpha-1 (IL22RA1)

Homo sapiens — UniProt Q8N6P7

Gene: IL22RA1Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Interleukin-22 receptor subunit alpha-1 (IL22RA1) is a protein from Homo sapiens identified by UniProt accession Q8N6P7, 574 residues long. MolForge cross-references it against 0 known binders and 205 disease associations.

  • UniProt accession: Q8N6P7; gene symbol IL22RA1.
  • Organism: Homo sapiens.
  • Length: 574 amino acids.
  • Top disease associations (Open Targets): C-reactive protein measurement, COVID-19 and cancer.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameInterleukin-22 receptor subunit alpha-1
UniProt accessionQ8N6P7
GeneIL22RA1
OrganismHomo sapiens
Length574 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (205)

Diseases linked to this target (Open Targets).

  • C-reactive protein measurement · score 0.32
  • COVID-19 · score 0.11
  • cancer · score 0.08
  • plasma fibronectin deficiency · score 0.06
  • glioblastoma multiforme · score 0.06
  • Crigler-Najjar syndrome type 2 · score 0.06
  • Miyoshi myopathy · score 0.05
  • metabolite measurement · score 0.05
  • transient familial neonatal hyperbilirubinemia · score 0.04
  • congenital enteropathy due to enteropeptidase deficiency · score 0.04

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q8N6P7-F1alphafoldPREDICTED61.71—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q8N6P7.

Amino-acid sequence (574 residues)

MRTLLTILTV GSLAAHAPED PSDLLQHVKF QSSNFENILT WDSGPEGTPD TVYSIEYKTY GERDWVAKKG CQRITRKSCN LTVETGNLTE LYYARVTAVS AGGRSATKMT DRFSSLQHTT LKPPDVTCIS KVRSIQMIVH PTPTPIRAGD GHRLTLEDIF HDLFYHLELQ VNRTYQMHLG GKQREYEFFG LTPDTEFLGT IMICVPTWAK ESAPYMCRVK TLPDRTWTYS FSGAFLFSMG FLVAVLCYLS YRYVTKPPAP PNSLNVQRVL TFQPLRFIQE HVLIPVFDLS GPSSLAQPVQ YSQIRVSGPR EPAGAPQRHS LSEITYLGQP DISILQPSNV PPPQILSPLS YAPNAAPEVG PPSYAPQVTP EAQFPFYAPQ AISKVQPSSY APQATPDSWP PSYGVCMEGS GKDSPTGTLS SPKHLRPKGQ LQKEPPAGSC MLGGLSLQEV TSLAMEESQE AKSLHQPLGI CTDRTSDPNV LHSGEEGTPQ YLKGQLPLLS SVQIEGHPMS LPLQPPSRPC SPSDQGPSPW GLLESLVCPK DEAKSPAPET SDLEQPTELD SLFRGLALTV QWES

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with IL22RA1?

The strongest Open Targets associations for IL22RA1 are C-reactive protein measurement, COVID-19, cancer, plasma fibronectin deficiency and glioblastoma multiforme.

How long is the IL22RA1 protein?

The Homo sapiens IL22RA1 protein (UniProt Q8N6P7) is 574 amino acids long.

Browse: Targets: I · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Interleukin-22 receptor subunit alpha-1 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ8N6P7
GeneIL22RA1
OrganismHomo sapiens
Length574
Binders0
Diseases205
View on UniProt